Affimed NV (AFMD)
4.30
+0.24
(+5.91%)
USD |
NASDAQ |
May 31, 16:00
4.32
+0.02
(+0.47%)
After-Hours: 20:00
Affimed Revenue (Annual): 8.959M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.959M |
| December 31, 2022 | 43.61M |
| December 31, 2021 | 47.76M |
| December 31, 2020 | 32.39M |
| December 31, 2019 | 23.95M |
| December 31, 2018 | 28.03M |
| Date | Value |
|---|---|
| December 31, 2017 | 2.276M |
| December 31, 2016 | 6.988M |
| December 31, 2015 | 8.392M |
| December 31, 2014 | 4.498M |
| December 31, 2013 | 6.756M |
| December 31, 2012 | 1.508M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
8.959M
Minimum
2023
47.76M
Maximum
2021
31.33M
Average
32.39M
Median
2020
Revenue (Annual) Benchmarks
| CureVac NV | 58.20M |
| InflaRx NV | 0.0683M |
| MorphoSys AG | 257.96M |
| BioNTech SE | 4.134B |
| Immatics NV | 58.46M |